Director, HTA, Value & Evidence (HV&E), Specialty Care, Brepocitinib (Med Rheum) (Secondment 6-8 Mon

WHY PATIENTS NEED YOU

Our focus is on patients and understanding the critical role our medicines play to produce better health outcomes. As a cross functional team of experts, we create and execute comprehensive value and access strategies through the integration of an evidence plan, health technology assessment, real-world evidence, and health economic modeling activities. Your expertise and innovative approach will support the planned launch of Brepocitinib in Europe, planned in 2027, demonstrating its value and enhancing its access to impact patient outcomes.

WHAT YOU WILL ACHIEVE

You will be part of Pfizer’s dynamic Global Access and Value (GAV) team and will support the development and execution of the HV&E strategy for Brepocitinib during a launch-critical period. The role will focus on advancing evidence generation and launch readiness activities, including:

• Review and the assessment of the Brepocitinib Clinical Study Report (CSR) to identify HEOR-relevant insights, evidence gaps and post-hoc analyses.

• Prioritization of evidence gaps and coordination of ownership across Global HEOR, country affiliates, and alliance partner.

• Contribution to the development and/or oversight of payer-relevant global launch evidence and narratives:

  • Cost-effectiveness and budget impact models.

  • Systematic Literature Reviews (Clinical, Economic, Humanistic, Epidemiology).

  • Indirect treatment comparisons / network meta-analyses.

  • Global Value Dossier.

  • Patient-reported outcome and quality-of-life evidence generation.

  • Real world evidence studies (e.g. treatment patterns, burden of illness/disease, epidemiology, real world effectiveness).

• Planning and execution.

• Collaboration with cross-functional partners (Global, Country and International Medical, Clinical, Value & Access, Commercial, Alliance teams) o ensure alignment.

HOW YOU WILL ACHIEVE IT

• Lead or support HTA, Value & Evidence workstreams in close partnership with cross-functional global and local teams.

• Ensure alignment of HTA, Value & Evidence activities with global strategy and launch timelines.

• Develop real world evidence generation strategies and lead the execution of studies (e.g., treatment patterns, real world effectiveness, burden of illness studies, epidemiology studies, etc.) to generate evidence to support brand competitive differentiation and value proposition.

• Lead the execution of clinically relevant and scientifically valid, cutting edge HV&E studies and projects (including non-interventional studies, registries, etc.) catered to diverse stakeholders (regulators, payers, patients, physicians and policy makers).

• Lead the development of appropriate data dissemination plans and communicate in a timely manner.

• Ensure all activities are conducted in compliance with Pfizer SOPs and governance requirements.

QUALIFICATIONS

Must-Have

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, oversee, and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

• BA/BS required with 8+ years of experience.

• Demonstrated expert understanding of fundamental health services research methods and tools including but not limited to:

• Health economics.

• Cost-effectiveness / budgetary impact modeling.

• Indirect treatment comparisons.

• Patient-reported outcomes / quality-of-life measures.

• Experience managing multiple projects and working in a matrix environment.

• Real world evidence studies.

• Demonstrated ability to assess anticipated value for projects/programs to ensure alignment to business priorities and prioritize accordingly.

• Strong interpersonal skills and evidence of teamwork in a matrix environment.

• Demonstrated ability to manage multiple projects with autonomy, involving complex processes, significant budget, competing deadlines, and rapidly shifting priorities in a compliant manner.

• Proven ability to develop strong partnerships across multiple functions within a large group/company.

• A track record with an “execution mindset” focused on getting things done quickly and simply.

• Ability to understand, synthesize, and summarize complex topics.

• Excellent oral and written English communication skills.

Nice-to-Have

• MBA/MS with 7+ years of experience; OR PharmD or PhD in HEOR or a closely related field such as health economics, epidemiology, health services research, or another research-oriented public health discipline with 5+ years if experience.

• Experience working with European HTA bodies such as NICE, CADTH, ICER and other reimbursement bodies is strongly preferred.

• Experience supporting launch assets.

• Knowledge and experience in I&I therapeutic areas is desirable.

• Launch experience is preferred.

OTHER JOB DETAILS

• Last Date to Apply for Job: February 6, 2026

• Additional Location Information: North America - Any Pfizer Site, Europe - Any Pfizer Site

• Eligible for Relocation Package – NO

• Secondment 6-8 months

• If you are currently in a driving position with a fleet vehicle and this secondment does not require driving as an essential function of the position for 12 months or longer, you will be required to turn in your fleet vehicle for the duration of the non-driving secondment.  Please refer to the Fleet Policy and Procedures document for more information.

• There will be no change to your current work location.

• Position is considered Flexible, and colleagues are expected to comply with Log In For Your Day (LIFYD) requirements at site location (e.g. about 2.5 days a week in office).

Relocation assistance may be available based on business needs and/or eligibility.